Abiomed Inc. Q2 Profit Increases, beats estimates

Abiomed Inc. (ABMD) reported earnings for its second quarter that increased from last year and beat the Street estimates.

The company's bottom line came in at $106.13 million, or $2.32 per share. This compares with $56.95 million, or $1.24 per share, in last year's second quarter.

Excluding items, Abiomed Inc. reported adjusted earnings of $59.4 million or $1.30 per share for the period.

Analysts on average had expected the company to earn $1.04 per share, according to figures compiled by Thomson Reuters. Analysts' estimates typically exclude special items.

The company's revenue for the quarter rose 7.2% to $265.92 million from $248.14 million last year.

Abiomed Inc. earnings at a glance (GAAP) :

-Earnings (Q2): $106.13 Mln. vs. $56.95 Mln. last year.
-EPS (Q2): $2.32 vs. $1.24 last year.
-Analyst Estimate: $1.04
-Revenue (Q2): $265.92 Mln vs. $248.14 Mln last year.

For comments and feedback contact: editorial@rttnews.com

Follow RTT